|
PPP2CA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.5141999999988E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.11339999999627E-05 |
| Normal-vs-Stage2 |
2.262100E-03 |
| Normal-vs-Stage3 |
2.948000E-01 |
| Normal-vs-Stage4 |
9.197400E-01 |
| Stage1-vs-Stage2 |
9.104400E-01 |
| Stage1-vs-Stage3 |
1.390560E-01 |
| Stage1-vs-Stage4 |
2.554800E-01 |
| Stage2-vs-Stage3 |
2.234400E-01 |
| Stage2-vs-Stage4 |
2.485400E-01 |
| Stage3-vs-Stage4 |
5.175400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7190999999992E-05 |
| Normal-vs-AfricanAmerican |
2.642700E-03 |
| Normal-vs-Asian |
6.729800E-01 |
| Caucasian-vs-AfricanAmerican |
5.631800E-01 |
| Caucasian-vs-Asian |
4.421000E-01 |
| AfricanAmerican-vs-Asian |
5.167400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76463000000071E-05 |
| Normal-vs-Female |
6.956100E-03 |
| Male-vs-Female |
2.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.441730E-02 |
| Normal-vs-Extreme_Weight |
3.033600E-04 |
| Normal-vs-Obese |
1.176190E-03 |
| Normal-vs-Extreme_Obese |
1.338410E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.102200E-01 |
| Normal_Weight-vs-Obese |
9.040400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.034800E-01 |
| Extreme_Weight-vs-Obese |
9.796600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.299600E-01 |
| Obese-vs-Extreme_Obese |
9.454800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.834100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.086340E-02 |
| Normal-vs-Age(61-80Yrs) |
7.74019999982833E-07 |
| Normal-vs-Age(81-100Yrs) |
3.004800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.903600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.183200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.224800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.133710E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.535400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.657600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.82323999999845E-05 |
| Normal-VS-Type2 PRCC |
6.832100E-02 |
| Normal-VS-KIRP CIMP |
4.447000E-04 |
| Normal-VS-Unclassified PRCC |
2.042200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.635170E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.223600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.989200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.683800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.657600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.134600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.84729999999878E-05 |
| Normal-vs-N1 |
8.791600E-01 |
| Normal-vs-N2 |
1.568240E-02 |
| N0-vs-N1 |
3.834100E-02 |
| N0-vs-N2 |
7.233400E-01 |
| N1-vs-N2 |
2.689600E-01 |
|
|
